BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35662499)

  • 1. Pathologic fracture in metastatic kidney cancer: Identifying widening disparities and opportunity for quality improvement.
    Bhanvadia RR; Baky FJ; Ashbrook CQ; Lotan Y; Woldu SL
    Urol Oncol; 2022 Aug; 40(8):384.e1-384.e8. PubMed ID: 35662499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients.
    Sammon JD; McKay RR; Kim SP; Sood A; Sukumar S; Hayn MH; Hu JC; Kibel AS; Nguyen PL; Peabody JO; Saad F; Sun M; Varda B; Menon M; Choueiri TK; Trinh QD
    Urology; 2015 Feb; 85(2):343-9. PubMed ID: 25623683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the 'weekend effect' in patients admitted with metastatic prostate cancer.
    Schmid M; Ghani KR; Choueiri TK; Sood A; Kapoor V; Abdollah F; Chun FK; Leow JJ; Olugbade K; Sammon JD; Menon M; Kibel AS; Fisch M; Nguyen PL; Trinh QD
    BJU Int; 2015 Dec; 116(6):911-9. PubMed ID: 25099032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases.
    Jairam V; Lee V; Yu JB; Park HS
    Am J Clin Oncol; 2020 Oct; 43(10):720-726. PubMed ID: 32694296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Prophylactic Intervention More Cost-effective Than the Treatment of Pathologic Fractures in Metastatic Bone Disease?
    Blank AT; Lerman DM; Patel NM; Rapp TB
    Clin Orthop Relat Res; 2016 Jul; 474(7):1563-70. PubMed ID: 27020430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for same-admission mortality after pathologic fracture secondary to metastatic cancer.
    Behnke NK; Baker DK; Xu S; Niemeier TE; Watson SL; Ponce BA
    Support Care Cancer; 2017 Feb; 25(2):513-521. PubMed ID: 27704262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasis.
    Antczak C; Trinh VQ; Sood A; Ravi P; Roghmann F; Trudeau V; Chang SL; Karakiewicz PI; Kibel AS; Krishna N; Nguyen PL; Saad F; Sammon JD; Sukumar S; Zorn KC; Sun M; Trinh QD
    J Urol; 2014 Jun; 191(6):1678-84. PubMed ID: 24384157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment for pathologic fracture.
    Wedin R
    Acta Orthop Scand Suppl; 2001 Jun; 72(302):2p., 1-29. PubMed ID: 11582636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Clinical and Economic Outcomes of Prophylactic and Acute Pathologic Fracture Treatment.
    Mosher ZA; Patel H; Ewing MA; Niemeier TE; Hess MC; Wilkinson EB; McGwin G; Ponce BA; Patt JC
    J Oncol Pract; 2019 Feb; 15(2):e132-e140. PubMed ID: 30523763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of skeletal-related events among elderly men with metastatic prostate cancer.
    Jayasekera J; Onukwugha E; Bikov K; Mullins CD; Seal B; Hussain A
    Pharmacoeconomics; 2014 Feb; 32(2):173-91. PubMed ID: 24435407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases?
    McLynn RP; Ondeck NT; Grauer JN; Lindskog DM
    Clin Orthop Relat Res; 2018 Dec; 476(12):2381-2388. PubMed ID: 30260860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pelvic and lower extremity fractures on the incidence of lower extremity deep vein thrombosis in high-risk trauma patients. Winner of the Best Paper Award from the Gold Medal Forum.
    Britt SL; Barker DE; Maxwell RA; Ciraulo DL; Richart CM; Burns RP
    Am Surg; 2003 Jun; 69(6):459-63; discussion 464. PubMed ID: 12852501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
    Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
    BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic bone disease: A review of survival, prognostic factors and outcomes following surgical treatment of the appendicular skeleton.
    Kirkinis MN; Lyne CJ; Wilson MD; Choong PF
    Eur J Surg Oncol; 2016 Dec; 42(12):1787-1797. PubMed ID: 27499111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Metastatic Spinal Tumor Frailty Index (MSTFI) Using a Nationwide Database and Its Association with Inpatient Morbidity, Mortality, and Length of Stay After Spine Surgery.
    De la Garza Ramos R; Goodwin CR; Jain A; Abu-Bonsrah N; Fisher CG; Bettegowda C; Sciubba DM
    World Neurosurg; 2016 Nov; 95():548-555.e4. PubMed ID: 27544340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression.
    Sutcliffe P; Connock M; Shyangdan D; Court R; Kandala NB; Clarke A
    Health Technol Assess; 2013 Sep; 17(42):1-274. PubMed ID: 24070110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoeconomics of bisphosphonates for skeletal-related event prevention in metastatic non-breast solid tumours.
    Carter JA; Joshi AD; Kaura S; Botteman MF
    Pharmacoeconomics; 2012 May; 30(5):373-86. PubMed ID: 22500986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humeral metastasis of renal cancer: Surgical options and review of literature.
    Casadei R; Drago G; Di Pressa F; Donati D
    Orthop Traumatol Surg Res; 2018 Jun; 104(4):533-538. PubMed ID: 29654934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of structural and economic factors on hospitalization costs, inpatient mortality, and treatment type of traumatic hip fractures in Switzerland.
    Mehra T; Moos RM; Seifert B; Bopp M; Senn O; Simmen HP; Neuhaus V; Ciritsis B
    Arch Osteoporos; 2017 Dec; 12(1):7. PubMed ID: 28013447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased resource use in men with metastatic prostate cancer does not result in improved survival or quality of care at the end of life.
    Golan R; Bernstein AN; Gu X; Dinerman BF; Sedrakyan A; Hu JC
    Cancer; 2018 May; 124(10):2212-2219. PubMed ID: 29579318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.